Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research
Status:
Unknown status
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
While trastuzumab has been shown to prevent recurrences of breast cancer, some women may also
experience damage to their heart muscle (including heart failure) as a result of their
treatment. The investigators hope to learn if standard medications used in heart failure can
prevent heart damage caused by trastuzumab in women with breast cancer. The investigators
would also like to know if there are any ways to detect this damage earlier using magnetic
resonance imaging (MRI) and blood tests.